Plasma sICAM-1 as a Biomarker of Carotid Plaque Inflammation in Patients with a Recent Ischemic Stroke


Por: Puig, N, Camps-Renom, P, Camacho, M, Aguilera-Simon, A, Jimenez-Altayo, F, Fernandez-Leon, A, Marin, R, Marti-Fabregas, J, Sanchez-Quesada, JL, Jimenez-Xarrie, E, Benitez, S

Publicada: 1 oct 2022 Ahead of Print: 1 mar 2022
Resumen:
F-18-fluorodeoxyglucose positron emission tomography (F-18-FDG PET) identifies carotid plaque inflammation and predicts stroke recurrence in patients with atherothrombotic stroke. The aim of the study was to identify plasma inflammatory biomarkers associated with plaque inflammation according to F-18-FDG uptake. We conducted a prospective study of consecutive adult patients with a recent (< 7 days) anterior circulation ischemic stroke and at least one atherosclerotic plaque in the ipsilateral internal carotid artery. We included 64 patients, 57.8% of whom showed a carotid stenosis >= 50%. All patients underwent an early (< 15 days from inclusion) F-18-FDG PET, and a blood sample was obtained at days 7 +/- 1 from the stroke. The plasma concentration of 16 inflammation-related molecules was analyzed in a Luminex using xMAP technology. Multivariable linear regression was used to assess the association between plasma biomarkers and the standardized uptake value (SUV) of F-18-FDG uptake. Soluble intercellular adhesion molecule-1 (sICAM-1), soluble vascular adhesion molecule-1 (sVCAM-1), and fractalkine (FKN) were independently associated with plaque inflammation (beta = 0.121, 95% CI 0.061-0.181, p < 0.001; beta = 0.144, 95% CI 0.012-0.276, p = 0.033; beta = 0.136, 95% CI 0.037-0.235, p = 0.008). In a multivariable logistic regression analysis, sICAM-1 was associated with SUVmax >= 2.85 (OR = 1.02, 95% CI 1.00-1.03, p = 0.020). Multivariable Cox regression was used to assess the association between biomarkers and stroke recurrence. sICAM-1 was associated with stroke recurrence (HR = 1.03, 95% CI 1.00-1.05, p = 0.002). In summary, elevated concentrations of sICAM-1 were associated with carotid plaque inflammation and an increased risk of stroke recurrence in patients with recent ischemic stroke and carotid atherosclerosis.

Filiaciones:
Puig, N:
 Biomed Res Inst St Pau IIB St Pau, Cardiovasc Biochem, Barcelona, Spain

 Univ Autonoma Barcelona UAB, Fac Med, Dept Biochem & Mol Biol, Bldg M, Barcelona, Spain

Camps-Renom, P:
 IIB St Pau, Stroke Unit, Hosp Santa Creu & St Pau, Dept Neurol, Barcelona, Spain

Camacho, M:
 Biomed Res Inst St Pau IIB St Pau, Genet Complexes Dis, Barcelona, Spain

Aguilera-Simon, A:
 IIB St Pau, Stroke Unit, Hosp Santa Creu & St Pau, Dept Neurol, Barcelona, Spain

Jimenez-Altayo, F:
 UAB, Neurosci Inst, Dept Pharmacol, Fac Med, Barcelona, Spain

Fernandez-Leon, A:
 IIB St Pau, Hosp Santa Creu & St Pau, Dept Nucl Med, Barcelona, Spain

Marin, R:
 IIB St Pau, Stroke Unit, Hosp Santa Creu & St Pau, Dept Neurol, Barcelona, Spain

Marti-Fabregas, J:
 IIB St Pau, Stroke Unit, Hosp Santa Creu & St Pau, Dept Neurol, Barcelona, Spain

Sanchez-Quesada, JL:
 Biomed Res Inst St Pau IIB St Pau, Cardiovasc Biochem, Barcelona, Spain

 CIBER Diabet & Metab Dis CIBERDEM, Madrid, Spain

Jimenez-Xarrie, E:
 IIB St Pau, Stroke Unit, Hosp Santa Creu & St Pau, Dept Neurol, Barcelona, Spain

Benitez, S:
 Biomed Res Inst St Pau IIB St Pau, Cardiovasc Biochem, Barcelona, Spain
ISSN: 18684483





Translational Stroke Research
Editorial
SPRINGER, ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES, USA
Tipo de documento: Article
Volumen: 13 Número: 5
Páginas: 745-756
WOS Id: 000763303300001
ID de PubMed: 35237947
imagen hybrid, All Open Access; Hybrid Gold

MÉTRICAS